These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34699264)

  • 1. Hypoxia Reduction Sensitizes Refractory Cancers to Immunotherapy.
    Jayaprakash P; Vignali PDA; Delgoffe GM; Curran MA
    Annu Rev Med; 2022 Jan; 73():251-265. PubMed ID: 34699264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Oxidative Phosphorylation to Increase the Efficacy of Radio- and Immune-Combination Therapy.
    Boreel DF; Span PN; Heskamp S; Adema GJ; Bussink J
    Clin Cancer Res; 2021 Jun; 27(11):2970-2978. PubMed ID: 33419779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo- and Immunotherapies.
    Klemba A; Bodnar L; Was H; Brodaczewska KK; Wcislo G; Szczylik CA; Kieda C
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33327450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia.
    Noman MZ; Hasmim M; Messai Y; Terry S; Kieda C; Janji B; Chouaib S
    Am J Physiol Cell Physiol; 2015 Nov; 309(9):C569-79. PubMed ID: 26310815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor T-cell Reconditioning: Improving Metabolic Fitness for Optimal Cancer Immunotherapy.
    Rivadeneira DB; Delgoffe GM
    Clin Cancer Res; 2018 Jun; 24(11):2473-2481. PubMed ID: 29386217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy.
    Jayaprakash P; Ai M; Liu A; Budhani P; Bartkowiak T; Sheng J; Ager C; Nicholas C; Jaiswal AR; Sun Y; Shah K; Balasubramanyam S; Li N; Wang G; Ning J; Zal A; Zal T; Curran MA
    J Clin Invest; 2018 Nov; 128(11):5137-5149. PubMed ID: 30188869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia.
    Scharping NE; Menk AV; Whetstone RD; Zeng X; Delgoffe GM
    Cancer Immunol Res; 2017 Jan; 5(1):9-16. PubMed ID: 27941003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy.
    Palazón A; Martínez-Forero I; Teijeira A; Morales-Kastresana A; Alfaro C; Sanmamed MF; Perez-Gracia JL; Peñuelas I; Hervás-Stubbs S; Rouzaut A; de Landázuri MO; Jure-Kunkel M; Aragonés J; Melero I
    Cancer Discov; 2012 Jul; 2(7):608-23. PubMed ID: 22719018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving Cancer Immunotherapy: Exploring and Targeting Metabolism in Hypoxia Microenvironment.
    Wei J; Hu M; Du H
    Front Immunol; 2022; 13():845923. PubMed ID: 35281061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.
    Chouaib S; Noman MZ; Kosmatopoulos K; Curran MA
    Oncogene; 2017 Jan; 36(4):439-445. PubMed ID: 27345407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment.
    Ma F; Vayalil J; Lee G; Wang Y; Peng G
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34642246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy.
    Lim AR; Rathmell WK; Rathmell JC
    Elife; 2020 May; 9():. PubMed ID: 32367803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia augments MHC class I antigen presentation via facilitation of ERO1-α-mediated oxidative folding in murine tumor cells.
    Kajiwara T; Tanaka T; Kukita K; Kutomi G; Saito K; Okuya K; Takaya A; Kochin V; Kanaseki T; Tsukahara T; Hirohashi Y; Torigoe T; Hirata K; Sato N; Tamura Y
    Eur J Immunol; 2016 Dec; 46(12):2842-2851. PubMed ID: 27667124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy.
    Wang B; Zhao Q; Zhang Y; Liu Z; Zheng Z; Liu S; Meng L; Xin Y; Jiang X
    J Exp Clin Cancer Res; 2021 Jan; 40(1):24. PubMed ID: 33422072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
    Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y
    Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma.
    Najjar YG; Menk AV; Sander C; Rao U; Karunamurthy A; Bhatia R; Zhai S; Kirkwood JM; Delgoffe GM
    JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30721155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the role of the tumor vasculature in antitumor immunity and immunotherapy.
    Schaaf MB; Garg AD; Agostinis P
    Cell Death Dis; 2018 Jan; 9(2):115. PubMed ID: 29371595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hypoxic tumour microenvironment: A safe haven for immunosuppressive cells and a therapeutic barrier to overcome.
    Chang WH; Lai AG
    Cancer Lett; 2020 Sep; 487():34-44. PubMed ID: 32470490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade.
    Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAM-Hijacked Immunoreaction Rescued by Hypoxia-Pathway-Intervened Strategy for Enhanced Metastatic Cancer Immunotherapy.
    Jiang T; Wang B; Wang T; Zhang L; Chen X; Zhao X
    Small; 2024 Feb; 20(5):e2305728. PubMed ID: 37752692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.